244 results on '"Benedet, Andrea L."'
Search Results
2. Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
3. CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
4. A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
5. 14-3-3 ζ/δ-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2
6. Vascular risk burden is a key player in the early progression of Alzheimer’s disease
7. A multicentre validation study of the diagnostic value of plasma neurofilament light.
8. Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies
9. Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
10. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
11. Staging of Alzheimer’s disease: past, present, and future perspectives
12. Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
13. Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
14. [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
15. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
16. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
17. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
18. Microglial activation and tau propagate jointly across Braak stages
19. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
20. APOEε4 potentiates the relationship between amyloid-β and tau pathologies
21. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease.
22. Plasma pTau217: single vs multiple phospho‐site assays.
23. Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer’s disease; relation to cognition, atrophy and synaptic density.
24. Independent associations of plasma GFAP with amyloid‐β and tau in Alzheimer’s disease
25. 14-3-3 $$\upzeta /\updelta$$-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2
26. Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals
27. Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
28. Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
29. Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
30. Concerns about the Future
31. A Young Missionary with Problems Quoting the Bible
32. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages
33. Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals.
34. Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals.
35. Topographical distribution of amyloid-β, tau and atrophy in behavioral / dysexecutive AD patients
36. Identifying incipient dementia individuals using machine learning and amyloid imaging
37. Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease
38. Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden
39. Synergistic interaction between amyloid and tau predicts the progression to dementia
40. A genome-wide association study of plasma phosphorylated tau181
41. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
42. Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest
43. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study
44. Aβ-induced vulnerability propagates via the brain’s default mode network
45. Comparison of Two Plasma P-Tau217 Assays to Detect and Monitor Alzheimer's Pathology
46. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions
47. Additional file 1 of CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
48. In vivo quantification of neurofibrillary tangles with [18F]MK-6240
49. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions.
50. Additional file 1 of Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.